Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00233038 · ClinicalTrials.gov registry record · Phase 2
EUS-Guided Pancreatic Injection of Cyst (EPIC) Trial
A Phase 2 study of Pancreatic Cystadenoma, sponsored by Massachusetts General Hospital.
- Completed
- Registry status
- Phase 2
- Development phase
- 50
- Enrollment target
- 1
- Study location
NCT00233038 is a Phase 2 study of Pancreatic Cystadenoma that has completed, run by Massachusetts General Hospital. The registered enrollment target is 50 participants. The trial reports 1 study location across 1 state.
The verdict
NCT00233038, a Phase 2 study of Pancreatic Cystadenoma, has completed, sponsored by Massachusetts General Hospital.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 50 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of the study is to learn about a new treatment for pancreatic cystic lesions. The injection of alcohol into cysts is a common way of treating cysts of the liver, kidney, and thyroid. We would like to find out if injection of alcohol would be useful for the treatment of pancreatic cystic lesions. The treatment with alcohol will use endoscopy and endoscopic ultrasound (procedures that use a scope that is placed through your mouth and into your stomach). We hypothesize that more than half of the cysts which are injected with ethanol will resolve.
Conditions Studied
Interventions
- PROCEDURE Ethanol injection into a cyst
Study Locations (1)
Indiana
- Indiana University Medical Center - Indianapolis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2005-01 |
| Est. Completion | 2008-03 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00233038
The ClinicalTrials.gov registry entry for NCT00233038 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 50 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Massachusetts General Hospital, which has 2,032 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Pancreatic Cystadenoma appearing as the primary indexed condition, and to 1 intervention - of which Ethanol injection into a cyst is the first listed.
NCT00233038 reports 1 study location spanning 1 distinct geographic area - top geographies include Indiana.
Frequently Asked Questions
What is clinical trial NCT00233038 about?
NCT00233038 is a clinical study titled "EUS-Guided Pancreatic Injection of Cyst (EPIC) Trial". The purpose of the study is to learn about a new treatment for pancreatic cystic lesions. The injection of alcohol into cysts is a common way of treating cysts of the liver, kidney, and thyroid. We would like to find out if injection of alcohol would be useful for the treatment of pancreatic cystic ...
What is the current status of trial NCT00233038?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 50 participants. The study started on 2005-01. Estimated completion is 2008-03.
What conditions does trial NCT00233038 study?
This clinical trial studies the following conditions: Pancreatic Cystadenoma.
What interventions are being tested in trial NCT00233038?
The interventions under investigation include: Ethanol injection into a cyst (PROCEDURE).
Who is sponsoring clinical trial NCT00233038?
This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00233038 being conducted?
This trial has 1 study location across Indiana. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.